抄録
Currently, there are no specific protein tyrosine kinase inhibitors available. This review summarizes our efforts to develop an active-site-directed inhibitor of pp60c-srv Initial efforts are directed at determining substrate specificity with synthetic peptides and at developing a biological system to test the potential of pp60c-src inhibitors to effectively inhibit the growth of pp60c-src activated cell lines. To meet these goals, we have developed new methods for purifying recombinant pp60C-SRC, assaying tyrosine kinase activity, synthesizing cyclic peptides, and generating random peptide libraries. In addition, we discuss the generation of potential artifacts while using polyhydroxy aromatic compounds as tyrosine kinase inhibitors.
| 本文言語 | 英語 |
|---|---|
| ページ(範囲) | 27-34 |
| ページ数 | 8 |
| ジャーナル | Pharmaceutical Biology |
| 巻 | 33 |
| 号 | S1 |
| DOI | |
| 出版ステータス | 出版済み - 1995 |
| 外部発表 | はい |
All Science Journal Classification (ASJC) codes
- 分子医療
- 薬理学
- 薬科学
- 創薬
- 補完代替医療
フィンガープリント
「Discovery, development, and testing of substrates and inhibitors of pp60c-SRC」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。引用スタイル
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver